Erythrocyte-derived ectosomes have immunosuppressive properties

Salima Sadallah1, Ceylan Eken, Jürg A Schifferli

  • 1Department of Biomedicine, University Hospital Basel, Basel, Switzerland. salima.sadallah@unibas.ch

Insights

Erythrocyte-derived microparticles (E-ecto) from stored blood exhibit immunosuppressive properties. These microparticles inhibit macrophage activation, potentially explaining the immunosuppressive effects of blood transfusions.

Area of Science:

  • Immunology
  • Hematology
  • Cell Biology

Background:

  • Clinical studies indicate blood transfusions possess immunosuppressive qualities.
  • While leukocyte-derived factors are known contributors, erythrocyte-derived microparticles' role remains unexplored.

Purpose of the Study:

  • To investigate the potential immunosuppressive role of microparticles released by erythrocytes during blood storage.
  • To characterize these erythrocyte-derived ectosomes (E-ecto) and their interaction with the immune system.

Main Methods:

  • Characterization of E-ecto for ectosome properties (size, lipid membrane, protein sorting).
  • Assessed complement activation (C1q, C3 fixation) and phosphatidylserine expression on E-ecto.
  • In vitro studies involving macrophage uptake of E-ecto and measurement of inflammatory cytokine release (TNF-alpha, IL-8) upon stimulation.

Main Results:

  • E-ecto demonstrated characteristics of ectosomes and initiated complement activation.
  • E-ecto expressed phosphatidylserine, suggesting immune regulatory potential.
  • Macrophages incubated with E-ecto showed significantly inhibited activation by zymosan A and LPS, with 80% and 76% reduction in TNF-alpha and IL-8, respectively.
  • This inhibitory effect was sustained for at least 24 hours.

Conclusions:

  • Erythrocyte-derived ectosomes (E-ecto) possess immunosuppressive properties by interfering with innate immune responses.
  • E-ecto may contribute to the observed immunosuppression associated with blood transfusions.

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview